Compared to free chemotherapeutic drugs, nano-sized drug delivery systems exhibit enhanced therapeutic effects and reduced in vivo toxicity. Peptide-based drug delivery systems have garnered significant attention due to the advantageous properties of peptides, including their excellent biocompatibility, diverse side-chain functionalities, and ability to form stable secondary structures. Incorporating stimuli-responsive amino acid residues or specific responsive moieties within their side chains endows these peptide-based drug delivery systems with unique stimuli-responsive characteristics. In this review, we summarize recent advancements and mechanisms in peptide-based nanodrug delivery systems that are capable of responding to one or multiple stimuli as well as conclude with a concise overview of the challenges that lie ahead in this field.
Stimuli-responsive peptide-based nanodrug delivery systems for tumor therapy.
Lei Zhou,Ting-Jie Zhang,Lu Zhang,Qiu-Ying Deng,Zhi-Yu Xia,Si-Lin Chen,Dong-Bing Cheng,Z. Qiao,Hao Wang
Published 2025 in Chemical Communications
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Chemical Communications
- Publication date
2025-04-28
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-4 of 4 citing papers · Page 1 of 1